IBRANCE (palbociclib)
ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+2
Parke-Davis Pfizer